Activity value 72china Supplier,Last transaction date:
2026-06-11
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for xiamen amoytop biotech co.ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 5 transactions, with a transaction quantity of 63613.36 and a transaction weight of 550.
YearTransactionsQuantityWeight
20251294139.641096
2026563613.36550
Bill of lading data
<
1/15
>
Trade date
2026/06/11
B/L No.
73199759015
Suppliers
xiamen amoytop biotech co.ltd.
Buyers
pharmakon biotech inc.
5пао фармсинтез
russiabuyer,they trade on 2019-05-13
42.40%
>
+View All
Products
Total 34
ProductsTransactionsPerDetail
vial 2681.25%>
top 2681.25%>
bat 2371.88%>
cancer 1753.13%>
vin 1753.13%>
+View All
Hscode rank
Total 16
HSCode NameTransactionsPerDetail
HS 300490992371.88%>
HS 3004909900039.38%>
HS 300215000026.25%>
HS 902519200026.25%>
HS 961700000113.13%>
+View All
Trading Area
Total 6
AreaTransactionsPerDetail
pakistan7746.11%>
peru5331.74%>
russia2112.57%>
philippines127.19%>
bangladesh21.20%>
+View All
Port statistics
Total 9
Port NameTransactionsPerDetail
xiamen2414.37%>
esmad95.39%>
madrid95.39%>
lulux63.59%>
miami31.80%>
+View All
xiamen amoytop biotech co.ltd. is china Supplier,
and primarily engages in the import and export business of products such as vial,top,bat.
According to the 52wmb.com global trade database, as of 2026-06-11, the company has completed 167 international trades,
with its main trading regions covering pakistan,peru,russia etc.
The core products include HS30049099,HS30049099000,HS3002150000 etc,
often transported via xiamen,port esmad, port madrid etc,
and its main trading partners are merixil pharma,laboratorios alpharma s.a.de c.v.,ооо нуклеокон.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on xiamen amoytop biotech co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.